PortfoliosLab logo
Sanofi (SNY)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US80105N1054

CUSIP

80105N105

IPO Date

Jul 1, 2002

Highlights

Market Cap

$129.11B

EPS (TTM)

$2.83

PE Ratio

18.49

PEG Ratio

0.90

Total Revenue (TTM)

$43.77B

Gross Profit (TTM)

$31.14B

EBITDA (TTM)

$7.32B

Year Range

$45.80 - $60.12

Target Price

$64.64

Short %

0.18%

Short Ratio

1.38

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Sanofi, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


250.00%300.00%350.00%400.00%450.00%500.00%NovemberDecember2025FebruaryMarchApril
289.30%
470.40%
SNY (Sanofi)
Benchmark (^GSPC)

Returns By Period

Sanofi had a return of 8.48% year-to-date (YTD) and 11.01% in the last 12 months. Over the past 10 years, Sanofi had an annualized return of 4.19%, while the S&P 500 had an annualized return of 10.15%, indicating that Sanofi did not perform as well as the benchmark.


SNY

YTD

8.48%

1M

-4.72%

6M

-3.72%

1Y

11.01%

5Y*

4.61%

10Y*

4.19%

^GSPC (Benchmark)

YTD

-6.06%

1M

-2.95%

6M

-4.87%

1Y

8.34%

5Y*

13.98%

10Y*

10.15%

*Annualized

Monthly Returns

The table below presents the monthly returns of SNY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202512.67%0.24%1.82%-5.66%8.48%
20240.34%-4.11%1.57%1.30%3.81%-1.04%6.78%8.59%2.44%-8.24%-8.30%-0.54%1.09%
20231.47%-4.66%16.16%-1.41%-1.18%5.64%-0.98%-0.36%0.86%-15.64%3.31%6.37%6.70%
20223.79%0.87%-2.12%1.77%5.92%-6.05%-0.66%-17.44%-7.34%13.70%4.90%6.79%0.47%
2021-2.84%-2.80%7.78%5.88%5.88%-1.44%-2.09%0.43%-6.89%4.60%-5.67%5.32%7.00%
2020-3.84%-4.18%-5.47%11.09%4.87%3.95%2.74%-3.57%-0.81%-9.71%10.82%-3.21%0.38%
20190.09%-4.26%6.44%-1.24%-3.69%7.02%-3.63%3.00%7.87%-0.54%1.30%7.54%20.47%
20182.16%-10.65%2.11%-1.90%2.25%4.55%8.37%-1.18%4.25%0.11%1.41%-4.28%6.06%
20170.84%5.76%4.92%4.53%8.28%-3.39%-1.15%3.12%1.95%-5.04%-3.47%-5.78%9.82%
2016-2.37%-5.02%1.54%2.34%4.46%1.58%1.86%-9.76%-0.73%1.83%3.37%0.60%-1.19%
20151.05%6.01%1.19%2.25%0.99%0.24%9.00%-9.39%-2.96%6.05%-12.16%-3.55%-3.39%
2014-8.82%6.01%0.85%2.91%2.68%-0.24%-1.69%4.65%3.16%-18.06%4.43%-5.55%-11.86%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SNY is 71, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SNY is 7171
Overall Rank
The Sharpe Ratio Rank of SNY is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of SNY is 6868
Sortino Ratio Rank
The Omega Ratio Rank of SNY is 6464
Omega Ratio Rank
The Calmar Ratio Rank of SNY is 7878
Calmar Ratio Rank
The Martin Ratio Rank of SNY is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Sanofi (SNY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for SNY, currently valued at 0.59, compared to the broader market-2.00-1.000.001.002.003.00
SNY: 0.59
^GSPC: 0.46
The chart of Sortino ratio for SNY, currently valued at 1.05, compared to the broader market-6.00-4.00-2.000.002.004.00
SNY: 1.05
^GSPC: 0.77
The chart of Omega ratio for SNY, currently valued at 1.12, compared to the broader market0.501.001.502.00
SNY: 1.12
^GSPC: 1.11
The chart of Calmar ratio for SNY, currently valued at 0.66, compared to the broader market0.001.002.003.004.005.00
SNY: 0.66
^GSPC: 0.47
The chart of Martin ratio for SNY, currently valued at 1.54, compared to the broader market-5.000.005.0010.0015.0020.00
SNY: 1.54
^GSPC: 1.94

The current Sanofi Sharpe ratio is 0.59. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Sanofi with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.59
0.46
SNY (Sanofi)
Benchmark (^GSPC)

Dividends

Dividend History

Sanofi provided a 3.89% dividend yield over the last twelve months, with an annual payout of $2.04 per share.


3.40%3.60%3.80%4.00%4.20%$0.00$0.50$1.00$1.50$2.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$2.04$2.04$1.90$2.04$1.91$1.75$1.74$1.86$1.58$1.63$1.62$1.91

Dividend yield

3.89%4.22%3.83%4.22%3.80%3.61%3.46%4.29%3.67%4.03%3.79%4.19%

Monthly Dividends

The table displays the monthly dividend distributions for Sanofi. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$2.04$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.04
2023$0.00$0.00$0.00$0.00$1.90$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.90
2022$0.00$0.00$0.00$0.00$2.04$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.04
2021$0.00$0.00$0.00$0.00$1.91$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.91
2020$0.00$0.00$0.00$1.75$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.75
2019$0.00$0.00$0.00$0.00$1.74$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.74
2018$0.00$0.00$0.00$0.00$1.86$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.86
2017$0.00$0.00$0.00$0.00$1.58$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.58
2016$0.00$0.00$0.00$0.00$1.63$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.63
2015$0.00$0.00$0.00$0.00$1.62$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.62
2014$1.91$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.91

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
SNY: 3.9%
Sanofi has a dividend yield of 3.89%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%1,200.0%
SNY: 102.3%
Sanofi has a payout ratio of 102.33%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-11.95%
-10.07%
SNY (Sanofi)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Sanofi. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sanofi was 46.65%, occurring on Mar 6, 2009. Recovery took 586 trading sessions.

The current Sanofi drawdown is 11.95%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.65%Jul 27, 2006657Mar 6, 2009586Jul 1, 20111243
-33.52%May 25, 202286Sep 27, 2022136Apr 13, 2023222
-30.8%Sep 23, 2014350Feb 11, 2016936Oct 30, 20191286
-28.97%Aug 12, 2002129Feb 13, 200373May 30, 2003202
-26.4%Feb 7, 202030Mar 20, 202050Jun 2, 202080

Volatility

Volatility Chart

The current Sanofi volatility is 9.91%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
9.91%
14.23%
SNY (Sanofi)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Sanofi over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Sanofi is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.0
SNY: 18.5
The chart displays the Price-to-Earnings (P/E) ratio for SNY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, SNY has a P/E ratio of 18.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
SNY: 0.9
The chart shows the Price/Earnings to Growth (PEG) ratio for SNY compared to other companies in the Drug Manufacturers - General industry. SNY currently has a PEG ratio of 0.9. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
2.04.06.08.010.0
SNY: 2.9
This chart shows the Price-to-Sales (P/S) ratio for SNY relative to other companies in the Drug Manufacturers - General industry. Currently, SNY has a P/S ratio of 2.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
SNY: 1.5
The chart illustrates the Price-to-Book (P/B) ratio for SNY in comparison with other companies in the Drug Manufacturers - General industry. Currently, SNY has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items